Home » Topics » Briefs » Other news to note

Other news to note
RSS

AnaptysBio triggers milestone payment from Merck & Co.

Jan. 7, 2011

Xoma and Servier sign agreement for anti-inflammatory candidate XOMA-052

Jan. 5, 2011

Santaris expands alliance with Pfizer for RNA-targeted medicines

Jan. 5, 2011

AMRI and Genentech enter licensing agreement for antibacterial agents

Jan. 5, 2011

Stryker completes purchase of Boston Scientific's neurovascular business

Jan. 4, 2011

ReCyte Therapeutics to develop treatments for cardiovascular and blood diseases

Jan. 4, 2011

Labopharm and Purdue Pharma amend license agreement for Ryzolt

Jan. 4, 2011

Astellas Pharma reflects on Q2 of fiscal year 2010

Jan. 4, 2011

McKesson acquires US Oncology

Jan. 3, 2011

Advanced Cell Technology enters stock purchase agreement with Socius

Jan. 3, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...